ERWINAZE
- Product NDC
- 57902-249
- 11-digit product format
- 579020249
- Labeler code
- 57902
- Product ID
- 57902-249_b5245dc8-c827-425b-b55e-e12673e70e7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Asparaginase
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Jazz Pharmaceuticals, Inc.
- Application
- BLA125359
- Marketing category
- BLA
- Marketing start
- 2011-11-18
- Marketing end
- 2021-07-23
- Substance
- ASPARAGINASE ERWINIA CHRYSANTHEMI
- Active strength
- 10000 [iU]/mL
- Pharmacologic classes
- Asparaginase [CS],Asparagine-specific Enzyme [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 57902-249-05 | 57902024905 | 5 VIAL, GLASS in 1 CARTON (57902-249-05) > 1 mL in 1 VIAL, GLASS (57902-249-01) | 2011-11-18 | 2021-07-23 | No | No | Current |